Trump pushes FDA to speed review of Regeneron and Eli Lilly COVID-19 treatments: report


Trump pushes FDA to speed review of Regeneron and Eli Lilly COVID-19 treatments: report



President Trump and White House Chief of Staff Mark Meadows have reportedly contacted Food and Drug Administration Commissioner Stephen Hahn urging him to accelerate the agency’s review of Regeneron Pharmaceuticals' antibody cocktail, sources familiar with the situation told the Washington Post.

Comments

Popular posts from this blog

Covid live: Record 50,000+ infections on Sunday

Impact of pandemic? Women jobseekers fell by 34% in 2021

SC slams trial courts for seeking needless custody